FenuSmart^®

Peri-menopause is a transformative phase for women, characterized by symptoms like hot flashes, night sweats, mood variations, and sexual health challenges, primarily due to hormonal shifts. Research on FenuSmart’s effectiveness shows significant life quality improvements by easing common peri-menopausal symptoms. Within just 42 days of taking FenuSmart, women experienced a 26% reduction in vasomotor symptoms, including hot flashes and night sweats, and a 31.8% decrease in depression rates. Women also experienced a 16.7% reduction in vaginal dryness and a 21.6% reduction is sleep issues. The study also revealed positive changes in hormone levels, with increases in estradiol (18.9%), free testosterone (38.2%), and progesterone (19.9%), alongside decreases in FSH by 38.2% and sex hormone-binding globulin (SHBG) by 21.1%. These results indicate that FenuSmart fosters a more balanced hormonal state, easing peri-menopausal discomforts, without adverse effects.

Supplementation with FenuSmart has been clinically shown to restore hormone levels, enhancing well-being in post-menopausal women. Specifically, supplementation has been shown to increase estradiol by 39.8%, total testosterone by 38.8%, and progesterone by 21.1% while simultaneously, reducing FSH by 25.1% and SHBG by 34.5%, maintaining these changes within healthy limits. FenuSmart supplementation offers significant relief from some of the most challenging symptoms of menopause. Specifically, it has been shown to reduce the severity of hot flashes by 47.8% and decrease their frequency to just once or twice daily, from an original three to five times. Impressively, about 32% of participants reported no hot flashes by the end of the study. Other significant improvements across the board included reductions in night sweats (53%), mood swings (69%), sleeplessness (71%), mood (49%), irritability (76%), apprehensiveness (60%), and headaches (46%). Additionally, FenuSmart has proven benefits for vaginal health, significantly enhancing moisture and decreasing vaginal dryness by 56.3%. These improvements not only alleviate discomfort but also positively affect intimacy during menopause. Drops in estrogen levels during menopause are associated with bone, muscle, and vascular health, which could result in leg discomfort. Participants taking 250 mg of FenuSmart twice daily reported a 7.2-fold reduction in somatic symptoms, like leg and body discomfort, improving mobility and daily function, further enhancing the quality of life during and beyond menopause. Maintaining healthy calcium and hemoglobin levels is crucial for the well-being of maturing women. Calcium is vital for bone health, while sufficient hemoglobin ensures efficient oxygen delivery, reducing fatigue and enhancing vitality during menopause. FenuSmart supplementation has been shown to increase hemoglobin by 8.9% and serum calcium by 2%, supporting both energy levels and bone health in post-menopausal women.